The HIV-1 Viral Protease Is Activated during Assembly and Budding Prior to Particle Release

Authors:

Abstract
HIV-1 protease inhibitors have been a mainstay of antiretroviral therapy for more than 2 decades. Although antiretroviral therapy is effective at controlling HIV-1 replication, persistent reservoirs of latently infected cells quickly reestablish replication if therapy is halted.
Funding Information
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (R01 AI140847)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (P30 AI036219)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (T32 AI127201)

This publication has 59 references indexed in Scilit: